SLC29A4 and Alzheimer disease: For example, differences in the expression of the multi-drug and toxin extrusion protein 1 (MATE1; SLC47A1) protein and the plasma membrane monoamine transporter (PMAT; SLC29A4) protein in brain capillaries isolated from healthy individuals compared to AD patients have been observed [15].